(PAND) –
-
Form 15-12B Pandion Therapeutics,
-
Form SC 13D/A Pandion Therapeutics, Filed by: GLAXOSMITHKLINE PLC
-
Form EFFECT Pandion Therapeutics,
-
Form EFFECT Pandion Therapeutics,
-
Form SC 13D/A Pandion Therapeutics, Filed by: AI Pan LLC
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Viney Joanne L.
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Goyal Vikas
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Crane Alan L
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Freedman Edward D.
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: BELOFF GREGG
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Kakkar Rahul
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Becker Daniel J.
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Fuglesang Christopher
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Sundy John
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Stagliano Nancy
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Dorton Katina
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Frail Donald
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Carroll Jill
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Carlo Rizzuto
-
Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Larson Eric D
-
Form S-8 POS Pandion Therapeutics,
-
Form S-8 POS Pandion Therapeutics,
-
Form POS AM Pandion Therapeutics,
-
Form POS AM Pandion Therapeutics,
-
Form 8-K Pandion Therapeutics, For: Apr 01
-
Form SC 14D9/A Pandion Therapeutics, Filed by: Pandion Therapeutics, Inc.
-
Form SC TO-T/A Pandion Therapeutics, Filed by: MERCK SHARP & DOHME CORP.
-
Merck (MRK) Completes Acquisition of Pandion Therapeutics (PAND)
-
Merck Completes Acquisition of Pandion Therapeutics
-
Form 25-NSE Pandion Therapeutics, Filed by: Nasdaq Stock Market LLC
-
Form 10-K/A Pandion Therapeutics, For: Dec 31
-
Form SC TO-T/A Pandion Therapeutics, Filed by: MERCK SHARP & DOHME CORP.
-
Form SC 14D9/A Pandion Therapeutics, Filed by: Pandion Therapeutics, Inc.
-
Form S-8 Pandion Therapeutics,
-
Form 10-K Pandion Therapeutics, For: Dec 31
-
Form SC 14D9 Pandion Therapeutics, Filed by: Pandion Therapeutics, Inc.
-
Form SC 13D Pandion Therapeutics, Filed by: AI Pan LLC
-
Form SC TO-T Pandion Therapeutics, Filed by: MERCK SHARP & DOHME CORP.
-
Merck (MRK) Begins Tender Offer to Acquire Pandion Therapeutics (PAND)
-
Merck Begins Tender Offer to Acquire Pandion Therapeutics
-
Form 3 Pandion Therapeutics, For: Feb 24 Filed by: MERCK SHARP & DOHME CORP.
-
Form SC 13D Pandion Therapeutics, Filed by: Merck & Co., Inc.
-
Form SC14D9C Pandion Therapeutics, Filed by: Pandion Therapeutics, Inc.
-
SVB Leerink Downgrades Pandion Therapeutics (PAND) to Market Perform
-
Form SC TO-C Pandion Therapeutics, Filed by: MERCK SHARP & DOHME CORP.
-
Morgan Stanley Downgrades Pandion Therapeutics (PAND) to Equalweight, Following Acquisition
-
PANDION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PAND and Encourages Investors to Contact the Firm
-
Pre-Open Stock Movers 02/25: (PAND) (GME) (KOSS) Higher; (PING) (GPRE) (PZZA) Lower (more...)
-
Form 8-K Pandion Therapeutics, For: Feb 24
-
Merck (MRK) to Acquire Pandion Therapeutics (PAND) for $60/Share in $1.85 Billion Deal
Back to PAND Stock Lookup